|
Title |
External Id |
|
Agency |
Next Deadline |
Details |
|
Molecular Characterization of Multiple Myeloma Ethnic Disparity (U01) |
RFA-FD-15-029 |
|
Food and Drug Administration (FDA) |
All deadlines have passed
|
Show Details (+)
Hide Details (-)
|
|
Notice of Intent Deadline of Jun 4, 2015 Has Passed
|
Title
Molecular Characterization of Multiple Myeloma Ethnic Disparity (U01)
Agencies
Food and Drug Administration (FDA)
Description
The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA's scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.
More Information
http://www.grants.gov/web/grants/view-opportunity.html?oppId=276770
Submission Limits
The applicant organization may submit one application.
Deadlines
Internal Notice of Intent |
Jun 4, 2015 |
Notification of Internal Competition |
Jun 5, 2015 |
Internal Pre-proposal |
Jun 12, 2015 |
Results of Internal Competition |
Jun 19, 2015 |
Agency Notice of Intent/Pre-proposal |
N/A |
Agency Proposal |
Jul 20, 2015
|
|
Submitting a notice of intent
Anyone wishing to submit a proposal for one of these programs should click on the appropriate link in the list above. To expedite the process of planning an internal competition, please submit your notice of intent as soon as you know you have an interest in the funding program. You are only required to include the name of the Principal Investigator, any co-PI's, and the subject or title of the proposed project. The deadline for the internal notice of intent is indicated above.